| Tony Y Eng, MD | |
|
1365 Clifton Rd Ne, Atlanta, GA 30322-4427 | |
| (404) 778-3473 | |
| Not Available |
| Full Name | Tony Y Eng |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 37 Years |
| Location | 1365 Clifton Rd Ne, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275640260 | NPI | - | NPPES |
| 014641904 | Medicaid | TX | |
| 014641905 | Other | TX | CSHCN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | K7280 (Texas) | Secondary |
| 2085R0001X | Radiology - Radiation Oncology | 079037 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph's Hospital Of Atlanta, Inc | Atlanta, GA | Hospital |
| Emory University Hospital Midtown | Atlanta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Emory Clinic, Inc | 8820901408 | 2687 |
News Archive
One in every 10 Americans has diabetes, and a third or more of those with the condition will develop kidney disease. It may be possible to live a long and healthy life with diabetes, but once kidney disease develops, the risk of dying prematurely increases significantly, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Whole-brain radiotherapy can be delivered more safely to patients with brain metastases by avoiding the hippocampus according to a randomized phase III NRG Oncology trial presented at the American Society for Radiation Oncology Annual Meeting.
Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them-but only if it was the right second agent.
A recent commentary suggests that the U.S. should spend roughly $197 million more than it currently does to research the impact of climate change on public health.
› Verified 3 days ago
| Entity Name | The Emory Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798229 PECOS PAC ID: 8820901408 Enrollment ID: O20031110000503 |
News Archive
One in every 10 Americans has diabetes, and a third or more of those with the condition will develop kidney disease. It may be possible to live a long and healthy life with diabetes, but once kidney disease develops, the risk of dying prematurely increases significantly, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Whole-brain radiotherapy can be delivered more safely to patients with brain metastases by avoiding the hippocampus according to a randomized phase III NRG Oncology trial presented at the American Society for Radiation Oncology Annual Meeting.
Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them-but only if it was the right second agent.
A recent commentary suggests that the U.S. should spend roughly $197 million more than it currently does to research the impact of climate change on public health.
› Verified 3 days ago
| Entity Name | Emory Medical Care Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063452381 PECOS PAC ID: 4981501814 Enrollment ID: O20031217000968 |
News Archive
One in every 10 Americans has diabetes, and a third or more of those with the condition will develop kidney disease. It may be possible to live a long and healthy life with diabetes, but once kidney disease develops, the risk of dying prematurely increases significantly, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Whole-brain radiotherapy can be delivered more safely to patients with brain metastases by avoiding the hippocampus according to a randomized phase III NRG Oncology trial presented at the American Society for Radiation Oncology Annual Meeting.
Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them-but only if it was the right second agent.
A recent commentary suggests that the U.S. should spend roughly $197 million more than it currently does to research the impact of climate change on public health.
› Verified 3 days ago
| Entity Name | Georgia Protoncare Center Inc. |
|---|---|
| Entity Type | Part B Supplier - Radiation Therapy Center |
| Entity Identifiers | NPI Number: 1083107999 PECOS PAC ID: 0749524312 Enrollment ID: O20181207002533 |
News Archive
One in every 10 Americans has diabetes, and a third or more of those with the condition will develop kidney disease. It may be possible to live a long and healthy life with diabetes, but once kidney disease develops, the risk of dying prematurely increases significantly, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Whole-brain radiotherapy can be delivered more safely to patients with brain metastases by avoiding the hippocampus according to a randomized phase III NRG Oncology trial presented at the American Society for Radiation Oncology Annual Meeting.
Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them-but only if it was the right second agent.
A recent commentary suggests that the U.S. should spend roughly $197 million more than it currently does to research the impact of climate change on public health.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tony Y Eng, MD 7703 Floyd Curl Dr, San Antonio, TX 78229-3901 Ph: (210) 257-1400 | Tony Y Eng, MD 1365 Clifton Rd Ne, Atlanta, GA 30322-4427 Ph: (404) 778-3473 |
News Archive
One in every 10 Americans has diabetes, and a third or more of those with the condition will develop kidney disease. It may be possible to live a long and healthy life with diabetes, but once kidney disease develops, the risk of dying prematurely increases significantly, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Whole-brain radiotherapy can be delivered more safely to patients with brain metastases by avoiding the hippocampus according to a randomized phase III NRG Oncology trial presented at the American Society for Radiation Oncology Annual Meeting.
Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them-but only if it was the right second agent.
A recent commentary suggests that the U.S. should spend roughly $197 million more than it currently does to research the impact of climate change on public health.
› Verified 3 days ago
Omar Nabil Kallas, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1364 Clifton Road, Department Of Radiology And Imaging Sciences, Atlanta, GA 30322 Phone: 404-778-3900 | |
Dr. Bijan Ghorashi, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 20 Glenlake Parkway, Kaiser Permanente Glenlake Medical, Atlanta, GA 30328 Phone: 404-365-0966 Fax: 606-666-6107 | |
Dr. George Oren Atkinson Jr., MD Radiology Medicare: Not Enrolled in Medicare Practice Location: Emory University Hospital, 1364 Clifton Road, Ne, Atlanta, GA 30322 Phone: 404-785-6547 Fax: 404-785-1216 | |
Dr. Fabio P Esteves, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1364 Clifton Rd Ne Radiology, Atlanta, GA 30322 Phone: 404-778-5586 | |
Amy J Figueroa, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Johnson Ferry Rd Ne, Atlanta, GA 30342 Phone: 404-851-8000 | |
Debora Lou Coursey-prah, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1968 Peachtree Rd Nw, Radiology Department, Atlanta, GA 30309 Phone: 404-605-5000 | |
Sachin Parikh, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1365 Clifton Rd Ne, Breast Imaging Center, Winship C, Atlanta, GA 30322 Phone: 404-778-1856 Fax: 404-712-7561 |